Literature DB >> 33330792

Response to the COVID-19 epidemic: a report from Shenzhen, China.

Xin Zhao1, Youchun Wu1, Zhiwei Li1, Lei Liu1.   

Abstract

The whole world is now facing an unprecedented pandemic with over 1.8 million confirmed cases and more than one hundred thousand deaths. To counter the pandemic, Shenzhen created a central command and control structure based on the only designated hospital- Shenzhen Third People's Hospital which is a large general hospital specialized on infectious diseases in the bay area. The hospital has taken many decisive and effective actions to respond to the epidemic. Here, we will describe and share healthcare experiences from Shenzhen and call for international cooperation and collaboration. 2020, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; China; Shenzhen; public health emergency

Year:  2020        PMID： 33330792      PMCID： PMC7731071          DOI： 10.35772/ghm.2020.01025

Source DB:  PubMed          Journal:  Glob Health Med        ISSN： 2434-9186


  8 in total

1.  Human neutralizing antibodies elicited by SARS-CoV-2 infection.

Authors:  Bin Ju; Qi Zhang; Jiwan Ge; Ruoke Wang; Jing Sun; Xiangyang Ge; Jiazhen Yu; Sisi Shan; Bing Zhou; Shuo Song; Xian Tang; Jinfang Yu; Jun Lan; Jing Yuan; Haiyan Wang; Juanjuan Zhao; Shuye Zhang; Youchun Wang; Xuanling Shi; Lei Liu; Jincun Zhao; Xinquan Wang; Zheng Zhang; Linqi Zhang
Journal:  Nature       Date:  2020-05-26       Impact factor: 49.962

2.  COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.

Authors:  Qingxian Cai; Deliang Huang; Pengcheng Ou; Hong Yu; Zhibin Zhu; Zhang Xia; Yinan Su; Zhenghua Ma; Yiming Zhang; Zhiwei Li; Qing He; Lei Liu; Yang Fu; Jun Chen
Journal:  Allergy       Date:  2020-04-17       Impact factor: 13.146

3.  Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Authors:  Chenguang Shen; Zhaoqin Wang; Fang Zhao; Yang Yang; Jinxiu Li; Jing Yuan; Fuxiang Wang; Delin Li; Minghui Yang; Li Xing; Jinli Wei; Haixia Xiao; Yan Yang; Jiuxin Qu; Ling Qing; Li Chen; Zhixiang Xu; Ling Peng; Yanjie Li; Haixia Zheng; Feng Chen; Kun Huang; Yujing Jiang; Dongjing Liu; Zheng Zhang; Yingxia Liu; Lei Liu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

4.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

Authors:  Jia-Hui Zeng; Ying-Xia Liu; Jing Yuan; Fu-Xiang Wang; Wei-Bo Wu; Jin-Xiu Li; Li-Fei Wang; Hong Gao; Yao Wang; Chang-Feng Dong; Yi-Jun Li; Xiao-Juan Xie; Cheng Feng; Lei Liu
Journal:  Infection       Date:  2020-04-10       Impact factor: 3.553

6.  Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.

Authors:  Jianghong An; Xuejiao Liao; Tongyang Xiao; Shen Qian; Jing Yuan; Haocheng Ye; Furong Qi; Chengguang Shen; Lifei Wang; Yang Liu; Xiaoya Cheng; Na Li; Qingxian Cai; Fang Wang; Jun Chen; Guojun Li; Qiu'e Cai; Yingxia Liu; Yunfang Wang; Feng Zhang; Yang Fu; Qing He; Xiaohua Tan; Lei Liu; Zheng Zhang
Journal:  Ann Transl Med       Date:  2020-09

7.  Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.

Authors:  Lu Chen; Meizhou Liu; Lei Liu; Guoming Zhang; Jiantao Wang; Zheng Zhang; Kun Qiao; Ting Huang; Miaohong Chen; Na Xin; Zuliang Huang
Journal:  Br J Ophthalmol       Date:  2020-04-07       Impact factor: 4.638

8.  Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.

Authors:  Wen-Hua Liang; Wei-Jie Guan; Cai-Chen Li; Yi-Min Li; Heng-Rui Liang; Yi Zhao; Xiao-Qing Liu; Ling Sang; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Wei Wang; Qi-Hua He; Zi-Sheng Chen; Sook-San Wong; Mark Zanin; Jun Liu; Xin Xu; Jun Huang; Jian-Fu Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zhan-Hong Xie; Zheng-Yi Ni; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-06-04       Impact factor: 16.671
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.